THE METABOLIC SYNDROME FROM THE VIEW POINT OF PUBLIC HEALTH : WITH SPECIAL REFERENCE TO NONALCOHOLIC FATTY LIVER DISEASE

作者: Chisato Murata , Yoshihisa Watanabe , Tetsu Watanabe

DOI: 10.11236/JPH.52.11_934

关键词:

摘要: Changes in human behavior and lifestyle over the last century have resulted a dramatic increase incidence of obesity, type 2 diabetes, metabolic syndrome. Differences reported overall prevalence syndrome, which is generally range 10-30% depend on diagnostic criteria subjects study. Recently, Japanese for diagnosis syndrome were defined. With these criteria, presence visceral obesity essential simply determined by measurement waist circumference. Reflecting increasing Japan as well Western countries, regardless applied. number workers with elevated liver enzymes, whom virus hepatitis, alcoholic disease, drug induced autoimmune iron overload ruled out causal agents, has also be found to at workplace health checkups. Most such components steatosis liver, this pathologic condition now being termed nonalcoholic fatty disease (NAFLD). In review, we describe relationship between NAFLD

参考文章(63)
Luc Djoussé, Donna K. Arnett, John H. Eckfeldt, Michael A. Province, Martha R. Singer, R. Curtis Ellison, Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obesity Research. ,vol. 12, pp. 1375- 1385 ,(2004) , 10.1038/OBY.2004.174
J. B. Meigs, P. W.F. Wilson, D. M. Nathan, R. B. D'Agostino, K. Williams, S. M. Haffner, Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. ,vol. 52, pp. 2160- 2167 ,(2003) , 10.2337/DIABETES.52.8.2160
Jeffrey D. Browning, Lidia S. Szczepaniak, Robert Dobbins, Pamela Nuremberg, Jay D. Horton, Jonathan C. Cohen, Scott M. Grundy, Helen H. Hobbs, Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity Hepatology. ,vol. 40, pp. 1387- 1395 ,(2004) , 10.1002/HEP.20466
H Vuorinen-Markkola, H Yki-Järvinen, Hyperuricemia and insulin resistance. The Journal of Clinical Endocrinology and Metabolism. ,vol. 78, pp. 25- 29 ,(1994) , 10.1210/JCEM.78.1.8288709
YUJI MATSUZAWA, TOHRU FUNAHASHI, TADASHI NAKAMURA, Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Annals of the New York Academy of Sciences. ,vol. 892, pp. 146- 154 ,(1999) , 10.1111/J.1749-6632.1999.TB07793.X
Kasturi Sen, Ruth Bonita, Global health status: two steps forward, one step back The Lancet. ,vol. 356, pp. 577- 582 ,(2000) , 10.1016/S0140-6736(00)02590-3
F Lönnqvist, A Thöme, K Nilsell, J Hoffstedt, P Arner, A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. Journal of Clinical Investigation. ,vol. 95, pp. 1109- 1116 ,(1995) , 10.1172/JCI117758
Eugenia E. Calle, Carmen Rodriguez, Kimberly Walker-Thurmond, Michael J. Thun, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine. ,vol. 348, pp. 1625- 1638 ,(2003) , 10.1056/NEJMOA021423